These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 31095572
21. Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial. Singata-Madliki M, Lawrie TA, Balakrishna Y, d'Hellencourt FC, Hofmeyr GJ. Reprod Health; 2021 Sep 29; 18(1):192. PubMed ID: 34587971 [Abstract] [Full Text] [Related]
28. Preventing recurrence of endometriosis by means of long-acting progestogen therapy (PRE-EMPT): report of an internal pilot, multi-arm, randomised controlled trial incorporating flexible entry design and adaption of design based on feasibility of recruitment. Middleton LJ, Daniels JP, Weckesser A, Bhattacharya S, PRE-EMPT trial collaborative group. Trials; 2017 Mar 11; 18(1):121. PubMed ID: 28283026 [Abstract] [Full Text] [Related]
30. Long-acting reversible contraception in adolescents. Morrell K. J Pediatr Adolesc Gynecol; 2012 Dec 11; 25(6):407-9. PubMed ID: 23304711 [No Abstract] [Full Text] [Related]
31. Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms. Hapgood JP, Kaushic C, Hel Z. Endocr Rev; 2018 Feb 01; 39(1):36-78. PubMed ID: 29309550 [Abstract] [Full Text] [Related]
32. Postpartum contraception: initiation and effectiveness in a large universal healthcare system. Brunson MR, Klein DA, Olsen CH, Weir LF, Roberts TA. Am J Obstet Gynecol; 2017 Jul 01; 217(1):55.e1-55.e9. PubMed ID: 28257962 [Abstract] [Full Text] [Related]
33. Long-acting reversible contraception: a review in special populations. Prescott GM, Matthews CM. Pharmacotherapy; 2014 Jan 01; 34(1):46-59. PubMed ID: 24130075 [Abstract] [Full Text] [Related]
34. Long-acting hormonal contraceptives for women. Garza-Flores J, Hall PE, Perez-Palacios G. J Steroid Biochem Mol Biol; 1991 Jan 01; 40(4-6):697-704. PubMed ID: 1958567 [Abstract] [Full Text] [Related]
35. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Critchley HO, Wang H, Kelly RW, Gebbie AE, Glasier AF. Hum Reprod; 1998 May 01; 13(5):1210-7. PubMed ID: 9647549 [Abstract] [Full Text] [Related]
36. Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial. Hofmeyr GJ, Singata-Madliki M, Batting J, Balakrishna Y, Morroni C. BMC Womens Health; 2024 Mar 08; 24(1):167. PubMed ID: 38459552 [Abstract] [Full Text] [Related]
37. Subdermal contraceptive implants. Peralta O, Diaz S, Croxatto H. J Steroid Biochem Mol Biol; 1995 Jun 08; 53(1-6):223-6. PubMed ID: 7626459 [Abstract] [Full Text] [Related]
38. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic. Bahamondes L, Bottura BF, Bahamondes MV, Gonçalves MP, Correia VM, Espejo-Arce X, Sousa MH, Monteiro I, Fernandes A. Hum Reprod; 2014 Oct 10; 29(10):2163-70. PubMed ID: 25085802 [Abstract] [Full Text] [Related]
39. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline. Mavranezouli I, LARC Guideline Development Group. Hum Reprod; 2008 Jun 10; 23(6):1338-45. PubMed ID: 18372257 [Abstract] [Full Text] [Related]
40. Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms. Skosana SB, Woodland JG, Cartwright M, Enfield K, Komane M, Louw-du Toit R, van der Spuy Z, Avenant C, Africander D, Storbeck KH, Hapgood JP. J Steroid Biochem Mol Biol; 2019 May 10; 189():145-153. PubMed ID: 30822501 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]